← Open Payments lookup

HYRUM DAVENPORT: Open Payments

NPI 1255567210 · CHUBBUCK, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,149 in 140 payments from 16 companies in 2025. Trend: 2023 $2,020 · 2024 $1,756 · 2025 $2,149

Food & beverage: $2,146Education: $4
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.16$312
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)19$311
ABBVIE INC.24$304
Vanda Pharmaceuticals Inc.14$258
Neurocrine BioSciences, Inc.20$227
Alkermes, Inc.16$208
Teva Pharmaceuticals USA, Inc.12$148
Tris Pharma Inc1$117
Janssen Pharmaceuticals, Inc3$57
E.R. Squibb & Sons, L.L.C.3$51

Products named: CAPLYTA, FANAPT, INGREZZA, REXULTI, VRAYLAR, ARISTADA, Onyda XR, ABILIFY ASIMTUFII.

Industry payments across ID — which companies pay providers there.